ACCC and ASCO collaborative targets disparities in cancer clinical trials

Am J Manag Care. 2021 Feb;27(2 Spec No.):SP67. doi: 10.37765/ajmc.2021.88647.

Abstract

ACCC president Randall Oyer, MD, gives insight into the ongoing collaboration between the ACCC and ASCO to foster minority participation in cancer clinical trials.

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Minority Groups
  • Neoplasms* / therapy